273 related articles for article (PubMed ID: 15167706)
1. Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase).
Marinaki AM; Ansari A; Duley JA; Arenas M; Sumi S; Lewis CM; Shobowale-Bakre el-M; Escuredo E; Fairbanks LD; Sanderson JD
Pharmacogenetics; 2004 Mar; 14(3):181-7. PubMed ID: 15167706
[TBL] [Abstract][Full Text] [Related]
2. Inosine triphosphate pyrophosphatase and thiopurine s-methyltransferase genotypes relationship to azathioprine-induced myelosuppression.
Zelinkova Z; Derijks LJ; Stokkers PC; Vogels EW; van Kampen AH; Curvers WL; Cohn D; van Deventer SJ; Hommes DW
Clin Gastroenterol Hepatol; 2006 Jan; 4(1):44-9. PubMed ID: 16431304
[TBL] [Abstract][Full Text] [Related]
3. Mutation in the ITPA gene predicts intolerance to azathioprine.
Marinaki AM; Duley JA; Arenas M; Ansari A; Sumi S; Lewis CM; Shobowale-Bakre M; Fairbanks LD; Sanderson J
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1393-7. PubMed ID: 15571265
[TBL] [Abstract][Full Text] [Related]
4. Thiopurine S-methyltransferase and inosine triphosphate pyrophosphohydrolase genes in Japanese patients with inflammatory bowel disease in whom adverse drug reactions were induced by azathioprine/6-mercaptopurine treatment.
Uchiyama K; Nakamura M; Kubota T; Yamane T; Fujise K; Tajiri H
J Gastroenterol; 2009; 44(3):197-203. PubMed ID: 19214663
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetic association with adverse drug reactions to azathioprine immunosuppressive therapy following liver transplantation.
Breen DP; Marinaki AM; Arenas M; Hayes PC
Liver Transpl; 2005 Jul; 11(7):826-833. PubMed ID: 15973722
[TBL] [Abstract][Full Text] [Related]
6. Association of inosine triphosphatase 94C>A and thiopurine S-methyltransferase deficiency with adverse events and study drop-outs under azathioprine therapy in a prospective Crohn disease study.
von Ahsen N; Armstrong VW; Behrens C; von Tirpitz C; Stallmach A; Herfarth H; Stein J; Bias P; Adler G; Shipkova M; Oellerich M; Kruis W; Reinshagen M; Schütz E
Clin Chem; 2005 Dec; 51(12):2282-8. PubMed ID: 16214825
[TBL] [Abstract][Full Text] [Related]
7. Lack of association between the ITPA 94C>A polymorphism and adverse effects from azathioprine.
Gearry RB; Roberts RL; Barclay ML; Kennedy MA
Pharmacogenetics; 2004 Nov; 14(11):779-81. PubMed ID: 15564886
[TBL] [Abstract][Full Text] [Related]
8. Association between inosine triphosphate pyrophosphohydrolase deficiency and azathioprine-related adverse drug reactions in the Chinese kidney transplant recipients.
Xiong H; Xin HW; Wu XC; Li Q; Xiong L; Yu AR
Fundam Clin Pharmacol; 2010 Jun; 24(3):393-400. PubMed ID: 19682085
[TBL] [Abstract][Full Text] [Related]
9. TPMT but not ITPA gene polymorphism influences the risk of azathioprine intolerance in renal transplant recipients.
Kurzawski M; Dziewanowski K; Lener A; Drozdzik M
Eur J Clin Pharmacol; 2009 May; 65(5):533-40. PubMed ID: 19229528
[TBL] [Abstract][Full Text] [Related]
10. Association between adverse effects under azathioprine therapy and inosine triphosphate pyrophosphatase activity in patients with chronic inflammatory bowel disease.
Shipkova M; Franz J; Abe M; Klett C; Wieland E; Andus T
Ther Drug Monit; 2011 Jun; 33(3):321-8. PubMed ID: 21544018
[TBL] [Abstract][Full Text] [Related]
11. TPMT and ITPA genetic variants in Lithuanian inflammatory bowel disease patients: Prevalence and azathioprine-related side effects.
Steponaitiene R; Kupcinskas J; Survilaite S; Varkalaite G; Jonaitis L; Kiudelis G; Denapiene G; Valantinas J; Skieceviciene J; Kupcinskas L
Adv Med Sci; 2016 Mar; 61(1):135-40. PubMed ID: 26674571
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics of thiopurine therapy in paediatric IBD patients.
De Ridder L; Van Dieren JM; Van Deventer HJ; Stokkers PC; Van der Woude JC; Van Vuuren AJ; Benninga MA; Escher JC; Hommes DW
Aliment Pharmacol Ther; 2006 Apr; 23(8):1137-41. PubMed ID: 16611274
[TBL] [Abstract][Full Text] [Related]
13. A pharmacogenetics study of TPMT and ITPA genes detects a relationship with side effects and clinical response in patients with inflammatory bowel disease receiving Azathioprine.
Zabala-Fernández W; Barreiro-de Acosta M; Echarri A; Carpio D; Lorenzo A; Castro J; Martínez-Ares D; Pereira S; Martin-Granizo I; Corton M; Carracedo A; Barros F
J Gastrointestin Liver Dis; 2011 Sep; 20(3):247-53. PubMed ID: 21961091
[TBL] [Abstract][Full Text] [Related]
14. Allele frequency of thiopurine methyltransferase and inosine triphosphate pyrophosphatase gene polymorphisms in Korean patients with inflammatory bowel diseases.
Cheon JH; Kim JH; Kim BY; Kim SW; Hong SY; Eun CS; Hong SS; Byeon JS; Kim TI; Han DS; Yang SK; Lee KR; Kim WH
Hepatogastroenterology; 2009; 56(90):421-3. PubMed ID: 19579612
[TBL] [Abstract][Full Text] [Related]
15. The effect of ITPA polymorphisms on the enzyme kinetic properties of human erythrocyte inosine triphosphatase toward its substrates ITP and 6-Thio-ITP.
Bakker JA; Lindhout M; Habets DD; van den Wijngaard A; Paulussen AD; Bierau J
Nucleosides Nucleotides Nucleic Acids; 2011 Nov; 30(11):839-49. PubMed ID: 22060550
[TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM
J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783
[TBL] [Abstract][Full Text] [Related]
17. Allele frequency of inosine triphosphate pyrophosphatase gene polymorphisms in a Japanese population.
Marinaki AM; Sumi S; Arenas M; Fairbanks L; Harihara S; Shimizu K; Ueta A; Duley JA
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1399-401. PubMed ID: 15571266
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics during standardised initiation of thiopurine treatment in inflammatory bowel disease.
Hindorf U; Lindqvist M; Peterson C; Söderkvist P; Ström M; Hjortswang H; Pousette A; Almer S
Gut; 2006 Oct; 55(10):1423-31. PubMed ID: 16543290
[TBL] [Abstract][Full Text] [Related]
19. A Prospective Study Evaluating Metabolic Capacity of Thiopurine and Associated Adverse Reactions in Japanese Patients with Inflammatory Bowel Disease (IBD).
Odahara S; Uchiyama K; Kubota T; Ito Z; Takami S; Kobayashi H; Saito K; Koido S; Ohkusa T
PLoS One; 2015; 10(9):e0137798. PubMed ID: 26360046
[TBL] [Abstract][Full Text] [Related]
20. Influences of thiopurine methyltransferase genotype and activity on thiopurine-induced leukopenia in Korean patients with inflammatory bowel disease: a retrospective cohort study.
Kim JH; Cheon JH; Hong SS; Eun CS; Byeon JS; Hong SY; Kim BY; Kwon SH; Kim SW; Han DS; Yang SK; Kim WH
J Clin Gastroenterol; 2010; 44(10):e242-8. PubMed ID: 20308917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
